Fortress Biotech, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Common Stock (Tables)

Common Stock (Tables)

9 Months Ended

Sep. 30, 2014

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Components of Stock-Based Compensation Expenses

The following table summarizes the stock-based compensation expense from stock option awards, restricted common stock awards, employee stock purchase programs and warrants for the three and nine months ended September 30, 2014 and 2013:

	For the three months ended				For the nine months ended
	September 30,				September 30,
($ in thousands)	2014		2013		2014		2013
Employee awards	$	1,460	$	1,158	$	4,035	$	3,174
Non-employee awards		24		106		47		758
Non-employee warrants				2				140
Total stock-based compensation expense	$	1,484	$	1,266	$	4,082	$	4,072

Summary of Stock Option Activity

The following table summarizes stock option activity:

	Outstanding Options				Weighted
				Total	Average
		Weighted		Weighted	Remaining
		Average		Average	Contractual
	Number of	Exercise		Intrinsic	Life (in)
	Shares	Price		Value	years)
At December 31, 2013	3,117,777	$	4.31	$		8.36
Options granted
Options exercised	(323,412)		1.84
Options cancelled	(630,000)		4.28
At September 30, 2014	2,164,365	$	4.69	$		7.64
Options vested and expected to vest	2,164,365	$	4.69	$		7.64
Options vested and exercisable	1,647,698	$	4.40	$		7.36

Nonvested Restricted Stock Shares Activity

The following table summarizes restricted stock activity:

	Restricted Stock
		Weighted
		Average Grant
	Number of	Date
	Shares	Fair Value
Unvested balance at December 31, 2013	3,958,692	$	1.93
Restricted stock granted	4,343,692		2.69
Restricted stock cancelled	(15,000)		2.69
Unvested balance at September 30, 2014	8,287,384	$	2.33

Summary of Warrant Activity

The following table summarizes warrant activity:

	Warrants
		Weighted
		Average Grant
	Number of	Date
	Shares	Fair Value
Outstanding at December 31, 2013	711,894	$	6.63
Warrants cancelled due to expiration	(26,833)		6.15
Outstanding at September 30, 2014	685,061	$	6.65

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details